.Common-Size Income Statement
Difficulty: Beginner
Bristol-Myers Squibb Co., Common-Size Consolidated Income Statement
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Net product sales | ||||||||||
| | Alliance and other revenues | ||||||||||
| | Revenues | % | | % | | % | | % | | % | |
| | Cost of products sold | ||||||||||
| | Gross margin | % | | % | | % | | % | | % | |
| | Marketing, selling and administrative | ||||||||||
| | Research and development | ||||||||||
| | Operating income | % | | % | | % | | % | | % | |
| | Interest expense | ||||||||||
| | Interest income | ||||||||||
| | Provision for restructuring | ||||||||||
| | Litigation and other settlements | ||||||||||
| | Equity in net income of affiliates | ||||||||||
| | Divestiture gains | ||||||||||
| | Royalties and licensing income | ||||||||||
| | Transition and other service fees | ||||||||||
| | Other alliance and licensing income | ||||||||||
| | Pension charges | ||||||||||
| | Intangible asset impairment | ||||||||||
| | Equity investment impairment | ||||||||||
| | Written option adjustment | ||||||||||
| | Loss on debt redemption | ||||||||||
| | Other | ||||||||||
| | Other income (expense), net | % | | % | | % | | % | | % | |
| | Earnings before income taxes | % | | % | | % | | % | | % | |
| | Provision for income taxes | ||||||||||
| | Net earnings | % | | % | | % | | % | | % | |
| | Noncontrolling interest | ||||||||||
| | Net earnings attributable to BMS | % | | % | | % | | % | | % | |
